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The prokaryotic clustered regularly interspaced short palindromic repeat (CRISPR)-associated system (Cas) is a
simple, robust and efficient technique for gene targeting in model organisms such as zebrafish, mice and rats. In
this report, we applied CRISPR technology to rabbits by microinjection of Cas9 mRNA and guided RNA (gRNA) into
the cytoplasm of pronuclear-stage embryos. We achieved biallelic gene knockout (KO) rabbits by injection of 1 gene
(IL2rg) or 2 gene (IL2rg and RAG1) Cas9 mRNA and gRNA with an efficiency of 100%. We also tested the efficiency
of multiple gene KOs in early rabbit embryos and found that the efficiency of simultaneous gene mutation on
target sites is as high as 100% for 3 genes (IL2rg, RAG1 and RAG2) and 33.3% for 5 genes (IL2rg, RAG1, RAG2,
TIKI1 and ALB). Our results demonstrate that the Cas9/gRNA system is a highly efficient and fast tool not only for
single-gene editing but also for multi-gene editing in rabbits.
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Mice have long been used as animal models for gene func-
tion studies and human diseases. However, due to dif-
ferences in the physiological traits and gene expression
between mice and humans, mouse models cannot repli-
cate the symptoms or pathology of human diseases in
some cases [1]. For example, a recent study indicated that
the genomic responses of inflammation in mouse models
correlate poorly with human conditions [2]. Thus, animal
models more similar to humans that can mimic complex
human conditions are urgently needed for translational
medical research.
Rabbits have more similarities with human beings in
terms of physiology, anatomy and genetics than mice and
rats [3]. Compared with large animals such as pigs and
monkeys, rabbits have a shorter gestation term and require
lower maintenance cost. All these advantages make rabbits
a more appropriate animal model for many diseases, such
as cardiovascular and metabolic diseases. However, prior* Correspondence: fan_nana@gibh.ac.cn; lai_liangxue@gibh.ac.cn
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unless otherwise stated.to the advent of newly emerging gene-editing technologies,
such as custom-made zinc-finger nucleases (ZFNs) [4] and
transcription activator-like effectors nucleases (TALENs)
[5], gene editing in rabbits was difficult because the ability
of rabbit embryonic stem cells (ESCs) or induced pluripo-
tent stem cells (iPSCs) to contribute to germ line transmis-
sion has not been successfully established and the efficiency
of somatic cell nuclear transfer (SCNT) in rabbits is much
lower than in other animals such as cattle, pigs, sheep and
mice [6]. Thus far, only a few successful cases of gene-
targeting rabbits have been reported.
Gene KO rabbits were successfully produced using
ZFN and TALEN technologies in 2011 and 2012, re-
spectively [3,7,8]. However, the possibility of producing
multi-gene KO rabbits using ZFNs and TALENs has not
been reported. In many cases, multiple genes must be
simultaneously knocked out in rabbits, given that many
diseases are caused by alteration of more than 1 gene, in
order to study gene interactions.
The latest gene-targeting technology, CRISPR/Cas sys-
tem [9,10], has been successfully applied to edit genes in
Drosophila [11,12], C. elegans [13], plants [14], zebrafish
[15-17], mouse [18], rat [19,20], livestock cells [21], hu-
man cells [22,23], monkey [24] and rabbit [25]. The
Cas9/gRNA system is developed by fusing 2 small RNA. This is an Open Access article distributed under the terms of the Creative
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gRNA, which guides the Cas9 protein to cleave specific
DNA [23,26]. The mechanism of Cas9/gRNA system for
editing specific genes is similar to ZFNs and TALENs
[3]: double-strand breakss are created in the targeted
sites, after which several base deletions or insertions
(indels) are brought in by non-homologous end-joining;
if a donor DNA homologous to the flanks of the double-
strand breaks is offered, precise DNA fragment replacement
will occur through homology-directed repair. Although the
techniques share similar mechanisms, the CRISPR/Cas sys-
tem has several advantages over ZFNs and TALENs. The
CRISPR/Cas system, for example, offers higher efficiency
and easier design steps. More importantly, it can potentially
target multiple genes in a single step because multiple
gRNAs can share the same endonuclease Cas9 for multiple
gene-KO [18,27]. Two gene-KO mice and 3 gene-KO rats
have been obtained by one step injection of Cas9 mRNA
and gRNA to zygotes [18,20].
In this report we applied CRISPR technology to rabbit by
microinjection of Cas9 mRNA and gRNA into the cyto-









Figure 1 Genome editing via the Cas9/gRNA system in rabbit. (A) Con
this study. The T7 promoter drives transcription of the gRNA, consisting of
signal. bGH polyA: bovine growth hormone poly-A. (B) Target sequence of
system. gRNA-targeting sequences are underlined and PAM sequences areefficiency of the technique and explore the feasibility of
generating multiple gene-KO in rabbits in a single step.
Results
The Cas9/gRNA system
We constructed a vector with the T7 promoter that can be
in vitro transcribed into Cas9 mRNA and gRNA (Figure 1A).
The sequences of all target sites (22 nucleotides or 23 nu-
cleotides) (Figure 1B) begin with GG at the 5’ end because
transcription is initiated from GG bases and ended with
the protospacer adjacent motif (PAM) NGG at the 3’ end,
which is indispensable for Cas9 binding and cleavage [27].
Generation of 1 gene-KO rabbits by Cas9/gRNA system
We selected the IL2rg gene (X-linked) as the first gene of
interest to test the efficiency of 1 gene-KO rabbits. A mix-
ture of Cas9 mRNA and gRNA for IL2rg was microinjected
into the cytoplasm of pronuclear-stage embryos with work-
ing concentrations of 200 ng/μL of Cas9 mRNA and
20 ng/μL of gRNA. Sixteen of 21 injected embryos devel-
oped into the blastocyst stage, and PCR products derived









structs and schematic illustration of the Cas9/gRNA system used in
a target sequence and a scaffold sequence. NLS: nuclear localization
the IL2rg, RAG1, RAG2, TIKI1 and ALB genes using the Cas9/gRNA
highlighted in red.
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in all 12 embryos. More strikingly, we detected no wild
type (WT) sequence among the 12 embryos. The indels of
IL2rg gene ranged from 30 base pair (bp) insertions to
21 bp deletions (Figure 2A). We then used this system to
produce IL2rg KO rabbits. A total of 66 embryos injected
with the same concentration of Cas9 mRNA and gRNA for
IL2rg were transferred to 5 pseudo-pregnant recipient rab-
bits. After about 1 month, 3 of 5 recipient mothers were
pregnant to term and gave birth to 8 live kits (5 males, 3 fe-
males) (Figure 2B). PCR-sequencing of the targeted site in
rabbits showed that all 5 male newborns were IL2rg KO in
X chromosome and all 3 female newborns were mutated
in both X chromosomes. The indels in the founders ranged
from 9 bp to 321 bp deletions (Figure 2C). All IL2rg KO
rabbits were alive for no more than 45 days because of
diarrhea, pulmonary infection or other causes, except the
#2 (female, lived for 229 days) rabbit, kept in conventional
housing conditions (Figure 2D). We performed the autop-
sies soon after their death and found that IL2rg KO rabbits
had undersized thymuses compared with age-matched WT
ones (Figure 2E).
To further confirm high gene KO efficiency in rabbits
by the Cas9/gRNA system, we repeated the experiment
with the same approach for another gene, TIKI1 [28].
For in vitro testing, we microinjected 10 pronuclear-
stage embryos with Cas9 mRNA and gRNA for TIKI1 at
the same concentration as IL2rg. A total of 8 blastocysts
were obtained and sequenced. Consistent with the re-
sults of IL2rg, the modification efficiency was also 100%
(8/8) amongst the embryos, and 4 of the 8 embryos were
modified in both alleles (50%) (Table 1). The indels of
the TIKI1 in the injected embryos ranged from 2 bp in-
sertions to 18 bp deletions (Figure 3A). Thirty embryos
injected with 200 ng/μL of Cas9 mRNA and 20 ng/μL of
gRNA for TIKI1 were transferred to 3 pseudo-pregnant
recipient rabbits. After about 1 month, 2 of 3 recipient
mothers were pregnant to term and gave birth to 5 live
kits (Figure 3B). PCR-sequencing of the targeted site in
rabbits showed that all 5 newborns were modified at the
TIKI1 gene site and that 3 out of 5 newborns were bial-
lelically modified. The indels in the founders ranged
from 1 bp insertions to 20 bp deletions (Figure 3C). The
#1, #2, and #3 TIKI1 KO rabbits were weak at birth and
died within 3 days. The #4 and #5 TIKI1 KO rabbits
have been alive for over 5 months with apparent normal







IL2rg 20/200 21 16 (76)
TIKI1 20/200 10 8 (80)
*Indicates embryos without detecting WT sequence.One step generation of 2 gene-KO rabbits by Cas9/gRNA
system
We tested the efficiency of 2 gene modification in 1 step
using the Cas9/gRNA system in rabbits. IL2rg and
RAG1 were chosen as the genes of interest. Rabbits with
a deficiency of IL2rg and RAG1 genes are expected to
be an important immunodeficient animal model without
mature T cells, B cells and NK cells [29]. A total of 67
zygotes co-injected with a mixture of Cas9 mRNA
(200 ng/μL), gRNA for IL2rg (20 ng/μL) and gRNA for
RAG1 (20 ng/μL) were transferred into 5 surrogate rab-
bits. After about 1 month of pregnancy, 2 out of 5 re-
cipient mothers developed to term and gave birth to 5
live kits (3 males, 2 females) (Figure 4A). DNA sequen-
cing of the PCR products spanning the targeted site
showed that both IL2rg and RAG1 genes were simultan-
eously modified in all 5 newborns. The RAG1 gene was
biallelically modified in all 5 rabbits and IL2rg gene bial-
lelically modified in both female rabbits. Two of the 5
kits carried the same mutation pattern in 2 alleles
(homozygous mutation) at the RAG1 locus. Mutations
of the IL2rg gene in the founders ranged from 8 bp in-
sertions to 331 bp deletions (Figure 4B, upper), whilst
those of the RAG1 gene ranged from 246 bp insertions
to 20 bp deletions (Figure 4B, lower). The #1, and #2
IL2rg/RAG1 KO rabbits were weak at birth and died
within 2 days. The other 3 IL2rg/RAG1 KO rabbits died
within 2 months (because of infection) when kept in
cleaner conditions in isolation after weaning. The thy-
mus phenotype of these KO rabbits was similar to IL2rg
KO rabbits (data not shown).
Simultaneous multi-gene KO in vitro rabbit embryos by
Cas9/gRNA system
We co-injected a mixture of 3 gRNAs targeting IL2rg,
RAG1 and RAG2 plus Cas9 mRNA into the cytoplasm
of pronuclear-stage embryos to test the feasibility of cre-
ating multi-gene KO rabbits. The working concentra-
tions were 20 ng/μL for each gRNA and 200 ng/μL for
Cas9 mRNA. Out of 24 injected embryos, 20 embryos
developed into the blastocyst stage (83.3%). All 20 blas-
tocysts were used for PCR and sequence tests. We suc-
cessfully obtained sequence data for all 3 genes in 16 of
the blastocysts. All 16 embryos (100%) showed triple-
gene mutations and 15 (93.8%) did not show WT
sequences for all 3 genes (Table 2). As shown in Additional
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1 13 3 (2 males, 1 female) 3 (100) 1 (100)
2 11 0 - -
3 12 0 - -
4 15 2 (2 females) 2 (100) 2 (100)
5 15 3 (3 males) 3 (100) -













IL2rg -/Y (#6, 45 d)
Figure 2 One gene (IL2rg)-KO rabbit embryos and newborn rabbits. (A) Sequenced mutations in the IL2rg gene in injected embryos.
Deletions are indicated by dashes, insertions are indicated in blue and substitutions are indicated in pink. (B) Generation of IL2rg KO rabbits via
the Cas9/gRNA system. Zygotes (n = 66) microinjected with 200 ng/μL of Cas9 mRNA and 20 ng/μL of gRNA for IL2rg were transferred to 5
recipient mothers, 3 of which gave birth to 8 live kits. (C) Detailed mutations of the IL2rg gene in the 8 KO founders. The number of founder KO
rabbits is shown in the left column. (D) Picture of 26 days old IL2rg KO rabbits. (E) The thymus of IL2rg KO rabbits was obviously smaller than
that from age-matched WT ones. In A and C, the WT sequence is shown at the top with the target sites in underline; the sizes of the deletions
(−) or insertions (+) are shown in the right column. At least 8 TA-clones for each embryos or KO rabbit were used for sequencing to obtain
detailed information of the mutation.
















TI #2 TCTGCCTCCTGCCCACGG--------------CGCGAGGCTCCCGCTTCTGCCAACTG -14
TCTGCCTCCTGCCCACGGGCGCTGTCCCGCGGCTGCGAGGCTCCCGCTTCTGCCAACTG +1
TI #3 TCTGCCTCCTGCCCACGGGCGCTGTCCCGCGGCCGCGAGGCTCCCGCTTCTGCCAACTG +1
TCTGCCTCCTGCCCACGGGCGCTGTCCCGCG-----AGGCTCCCGCTTCTGCCAACTG -5









No. of embryos 
transferred
No. of newborns




1 8 0 - -
2 14 3 3 (100) 1 (33.3)
3 8 2 2 (100) 2 (100)
Total 30 5 5 (100) 3 (60)
Figure 3 One gene (TIKI1)-KO rabbit embryos and newborn rabbits. (A) Sequenced mutations in the TIKI1 gene in injected embryos.
Deletions are indicated by dashes and insertions are indicated in blue. (B) Generation of TIKI1 KO rabbits by the Cas9/gRNA system. The zygotes
(n = 30) microinjection with the 200 ng/μL of Cas9 mRNA and 20 ng/μL of gRNA for TIKI1 were transferred to 3 recipient mothers, 2 of which
gave birth to 5 live kits. (C) Detailed mutations of the TIKI1 gene in the 5 KO founders. The number of founder KO rabbits is shown in the left
column. In A and C, the WT sequence is shown at the top with the target sites in underline, and the sizes of the deletions (−) or insertions (+)
are shown in the right column.
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9 bp deletions for the RAG1 gene and 1 bp insertions to
15 bp deletions for the RAG2 gene.
The high efficiency of successful targeting of 3 genes in
in vitro cultured embryos encouraged us to determine
whether or not the Cas9/gRNA system has the capacity to
knock out more genes simultaneously in 1 step. We micro-
injected a mixture of 5 gRNAs targeting IL2rg, RAG1,
RAG2, TIKI1 and ALB combined with Cas9 mRNA into
pronuclear embryos. The working concentrations were
20 ng/μL for each gRNA and 200 ng/μL for Cas9 mRNA.
Out of 39 injected embryos, 20 developed into blastocyst
stage (51.3%), lower than that in the 3 gene-KO group. We
successfully obtained sequence data for all 5 genes in
12 embryos. As shown in Table 3, 1 to 5 mutations could
be found in an individual embryo and 4 sequenced embryos
were discovered with 5 genes edited simultaneously
(33.3%). More interestingly, 1 embryo did not show WT se-
quences for all 5 genes. The detailed mutation patterns of
the 5 genes are presented in Additional file 1: Figure S1B.Off-target analysis of newborn rabbits
Several studies have suggested that the 8–12 bases (seed
sequence) of the gRNA sequence close to PAM and
PAM itself are critical factors determining site-specific
cleavage. In other words, slight mismatches beyond the
seed sequence may lead to off-target cleavage [27]. To
detect the occurrence of off-target mutations in all 18
newborn rabbits (8 IL2rg KO rabbits, 5 TIKI1 KO rab-
bits and 5 IL2rg/RAG1 KO rabbits), we selected candi-
date sites with over 14 bases identical to the targeted
sites of IL2rg, TIKI1 and RAG1. Nine sites (IOT1 to
IOT9) were determined to be potential off-targeting sites
for the IL2rg gene, 17 sites (TOT1 to TOT17) were de-
termined to be potential off-targeting sites for the TIKI1
gene, whilst 3 sites (ROT1 to ROT3) were determined to
be potential off-targeting sites for the RAG1 gene in the
rabbit genome (Additional file 2: Figure S2). T7 endo-
nuclease I (T7EI) assay showed that only the IOT5 site
presented detectable mutagenic activity amongst these 29























1 9 0 - - - -
2 15 0 - - - -
3 14 0 - - - -
4 15 2 (2 males) 2 (100) 2 (100) - 2 (100)
5 14
3 (1 male, 
2 females )
3 (100) 3 (100) 2 (100) 3 (100)































Figure 4 Two gene-KO rabbits obtained by the Cas9/gRNA system in a single step. (A) Generation of 2 gene-KO (IL2rg/RAG1) rabbits via
the Cas9/gRNA system. Zygotes (n = 67) were microinjected with 200 ng/μL of Cas9 mRNA, 20 ng/μL of gRNA for IL2rg and 20 ng/μL of gRNA
for RAG1 and transferred into 5 recipient mothers, 2 of which gave birth to 5 live kits. (B) Detailed mutations of the IL2rg and RAG1 genes in the
5 KO founders. The number of founder KO rabbits is shown in the left column. For each gene, the WT sequence is shown at the top with the
target sites in underline, deletions are indicated by dashes and insertions are indicated in blue, and the sizes of the deletions (−) or insertions (+)
are shown in the right column.
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the DNA sequences of PCR products. Mutations at the
IOT5 site occurred around the PAM region (Figure 5B).
DNA sequencing showed that 5 (#1, #3, #5, #6, #2-4) of 13
founders had mutations at the IOT5 site. Details of these
mutations are shown in Figure 5C.
Discussion
In this report, we describe the feasibility of applying the
Cas9/gRNA system to create multi-gene KO rabbits. In
















IL2rg 18 18 (100)
RAG1 20/20/20/
200
24 20 (83.3) 19 19 (100)
RAG2 16 16 (100)
*indicates embryos without detecting WT sequence.to generate single gene-KO rabbits (IL2R or TIKI1). We
found that the efficiency of single gene modification is as
high as 100% in both in vitro embryos and newborn rab-
bits. In our previous study using TALEN technology to
generate KO rabbits, we were unable to achieve such a
high efficiency [8]. The mutation patterns derived from
Cas9/gRNA technology included chimera with at least 2
different genetic modifications, biallelic mutation and
homozygote, similar to that using TALENs [8]. However,
on account of its easy design, low time consumption and














17 (89.5) 18/18 (100) 16/16 (100) 15/16 (93.75)*
16 (100)















































IL2rg 12 11 (91.7) 11 (91.7) *




39 20 (51.3) 14 12 (85.7) 10 (71.4) 11/12 (91.7) 7/12 (58.3) 6/12 (50.0) 4/12 (33.3) 1/12 (8.33)*
TIKI1 14 9 (64.3) 6 (42.9)
ALB 19 11 (57.9) 5 (26.3)
*indicates embryos without detecting WT sequence.
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the targeting sequences can be determined by simply select-
ing the sequences with GGN18NGG or GGN17NGG (tar-
get sites are 19 nucleotides or 20 nucleotides or even
shorter like 17 nucleotides and 18 nucleotides [30]). The ol-
igonucleotides can be artificially synthesized and annealed
into a double-strand DNA with cohesive terminus, which
then can be cloned into the gRNA vector. The whole
process can be completed within 2 days.
Encouraged by the high efficiency of the Cas9/gRNA
system for editing 1 gene, we injected 2 gRNAs targeting
IL2rg and RAG1 and Cas9 mRNA into one-cell stage













Figure 5 Off-target analysis of Cas9/gRNA system-induced mutations
off-target sites using the pooled DNA of all KO founders for each gene as t
The IOT5 could be cleaved (red arrowheads). (B) Sequencing diagram of IO
mutation around the PAM region. (C) Detailed mutations of IOT5 in the ne
column. The WT sequence is shown at the top with the target sites in und
blue and substitutions are indicated in pink, and the sizes of the deletions
indicate the read number of the mutant allele (numerator) out of total readKO in a single step. Results indicated that all 5 new-
borns were simultaneously modified at the IL2rg and
RAG1 genes. Moreover, the RAG1 gene was biallelically
modified in all 5 kits and IL2rg was modified in both al-
leles of all 2 female kits, consistent with the findings in
mice [18]. More interestingly, we also found that 1 of
these rabbits carried the same mutation at the same
locus in the 2 alleles, a result that is similar to homozy-
gotes created by traditional homologous recombination.
This finding has not been described in similar work with
mice [18].
Because site-specific cleavage depends on gRNA and
all gRNAs share the same Cas9 enzyme, we speculatedTGGGGGAGTCACAGATTCACATCTTAG WT
AGCCACACGACTGGGGGAGTCACAGATTC +11 (2/6)
----- ACT--CAGATTCACATCTTAG -8 (4/6)
ACAGATTCACATCTTAG -21 (3/6)
-------- TTCACATCTTAG -20 (6/6)
-------- ACAGATTCACATCTTAG -10 (1/6)
T-- TCA-- CACAGATTCACATCTTAG -10 (1/6)
PAM
B
in KO founders. (A) T7EI assays of the PCR products of candidate
he template (primer sequences listed in Additional file 3: Table S2).
T5 in #1 IL2rg KO new-born rabbits showing a double curve after the
wborn rabbits. The number of founder KO rabbits is shown in the left
erline. Deletions are indicated by dashes, insertions are indicated in
(−) or insertions (+) are shown in the right column. The fractions
number (denominator).
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co-injecting several gRNAs together with Cas9 mRNA
into pronuclear-stage rabbit embryos. We explored this
feasibility using in vitro developmental rabbit embryos.
We co-injected a mixture of 3 gRNAs combined with
Cas9 mRNA into the cytoplasm of pronuclear-stage em-
bryos using a similar methodology employed in rats [20].
The efficiency of 3 gene-KO was also highly favourable:
all 15 embryos tested had 3 gene mutations and all 3
genes were biallelically mutated simultaneously. We then
extended the number of injected gRNAs to 5. To date, a
similar trial has yet to be reported in rabbits or other
mammals. A variety of mutations (1 to 5) were observed.
Four embryos (33.3%) had 5 genes knocked out simul-
taneously. This efficiency is favorable enough for prac-
tical application in the generation of multi-gene KO
rabbits. The in vitro development of embryos was not
substantially affected since there was 83% survival to
blastocyst in the 3 gRNA-injected embryos, while there
was a modest effect for the 5 gRNA-injected embryos
(51.3% survival to blastocyst). In our previous studies
using TALEN technology we achieved 36% survival to
blastocyst for RAG2 [8] and in the study using the Cas9/
gRNA system by Yang et al. there was 49.2% survival to
blastocyst for APOE [25]. Therefore, achieving KO rabbits
with mutations of 5 genes in 1 step might be also feasible
when transferring targeted embryos into surrogates.
Off-targeting is a major concern in gene editing tech-
nology, and analysis of off-target events in the founder
animals is a necessity. Several previous studies have
shown that the seed sequence is a key factor in deter-
mining the targeting specificity of the Cas9/gRNA sys-
tem. Off-targeting is more commonly observed when
the matched sequences are located closer to the PAM
[27]. In our study, off-target mutations were found in 5
out of 13 founders and only occurred at the IOT5 site.
However, this site is supposed to be a less likely candi-
date for off-target effects than the IOT1, IOT3 and
IOT4 sites. The reason behind this event is unknown.
However, mutations at IOT5 did not affect the birth and
phenotype of IL2rg KO rabbits. There are many reported
strategies to reduce off-targets of the Cas9/gRNA sys-
tem, such as the ‘paired nicking’ system [31] or trun-
cated gRNA [30]. Reducing the concentration of injected
gRNA and Cas9 mRNA may also decrease the efficiency
of off-targets, but at the expense of decreasing cleavage
on on-target site [32].
Besides zygote microinjection to generate KO rabbits,
SCNT and ESCs or iPSCs might also be applied to gen-
erate KO rabbits. However, the ability of rabbit ES cells
or iPS cells to contribute to germ line transmission has
not been successfully established and the efficiency of
SCNT in rabbits is much lower. So it is a long way to go
before using ESCs or iPSCsand SCNT to generate KOrabbits, and zygote microinjection is a relatively easy
technology to generate KO rabbits.
The IL2rg-KO rabbits generated in this study will be
used for experiments like cell transplantation therapy
and xenotransplantation, which maybe useful to bridge
the gap between small animals and large animals.
While this manuscript was in preparation, Yang et al.
reported the Cas9/gRNA system was feasible to edit
genes in rabbits. However, the average efficiency of 1
gene-KO in rabbits in our study is higher than that in
this report (100% compared to 52.6% in rabbits embryos
and 100% to 55.9% for newborn rabbits), and we
knocked out multiple genes at a time while they just
knocked out 1 gene at a time. Moreover, Yang et al. did
not analyze the off-targets.
In conclusion, the Cas9/gRNA system is a highly effi-
cient and fast tool for generating gene KO in rabbits and
can be utilized to construct multiple gene modifications in
1 step. Application of the Cas9/gRNA system will greatly
promote genetic engineering of rabbits, which will aid in
determining gene functions and establishing valuable
modified-animal models for human disease research.
Methods
Animals
The rabbits used in this study were New Zealand rabbits
strain and were purchased from the Laboratory Animal
Centre of Southern Medical University. Animal experi-
ments were approved by the Animal Research Ethics
Committee of the Guangzhou Institutes of Biomedicine
and Health, Chinese Academy of Sciences.
gRNA design
Sequences of GGN18NGG or GGN17NGG in the sense
or antisense strand of the DNA were selected as the tar-
get sites. Two DNA oligos (s1: 5’-ATAGGN18 [or N17]
GT-3’; s2: 5’-TAAAC plus the reverse complement of
GGN18 [or GGN17]-3’ ) were synthesized for each tar-
geted site. The 2 DNA oligos (10 μM) were annealed in
New England Biolabs (NEB) buffer 3 under previously
described conditions [16]. A mixture of 4 μL of annealed
solution, 5 μL of solution I (Takara) and 1 μL of purified
gRNA cloning vector (Figure 1A) digested with Bbs I
(Thermo) was maintained at 16°C for 30 minutes and
then transformed into competent bacteria for plasmid
preparation and subsequent sequencing analysis to select
the correct gRNA containing the target site sequence.
RNA synthesis
The Cas9 expression vector (from Addgene) was linearized
with Pme I (Thermo) and purified with an agarose gel
DNA extraction kit (Takara). The Cas9 mRNA was tran-
scribed with mMESSAGE mMACHINE® T7 Kit (Ambion),
poly (A) tailed with E. coli Poly (A) Polymerase (NEB) and
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the manufacturer’s protocol.
The templates of gRNA for in vitro transcription of
RNA were purified PCR products obtained from gRNA
vectors using the primer pair (T7-F: 5’-GAAATTAATAC
GACTCACTATA-3’ and T7-R: 5’-AAAAAAAGCACC
GACTCGGTGCCAC-3’) with a high-fidelity enzyme
(Takara). The gRNA was transcribed using a T7 High Yield
RNA Synthesis Kit (NEB) and purified by lithium chloride
precipitation following the manufacturer’s protocol.
The quality of the synthesised RNA was analysed by
1% agarose gel electrophoresis at 200 V for 8 minutes,
and its concentration was determined by spectropho-
tometry. All of the reagents used in the experiments
above were RNase-free.
Collection of rabbit zygotes
Zygotes were collected from superovulated donor rabbits
as previously described [8]. Briefly, sexually mature rabbits
were injected with 100 IU pregnant mare serum gonado-
trophin intramuscularly. About 72 hours later, the rabbits
were mated and then injected with 100 IU human chori-
onic gonadotrophin (hCG) intravenously. The day after
mating (about 10 hours to 20 hours later), donor rabbits
were sacrificed and zygotes were flushed from the oviducts
with pre-warmed embryo manipulation medium (M199).
Pronuclear-stage zygotes were transferred to embryo cul-
ture medium for microinjection.
Microinjection of the Cas9 mRNA and gRNA mixture into
zygotes
The final concentration of each gRNA in the mixture so-
lution was 20 ng/μL, and the Cas9 mRNA concentration
was 200 ng/μL. Approximately 5–10 pL of the mixture
liquid was injected into the cytoplasm of pronuclear-
stage embryos using an injection pipette on a heated
microscope stage set at 37.5°C. The injected embryos
were transferred to embryo culture medium for either
about 5 days to blastocyst stage for in vitro embryo de-
velopment testing or 2–3 hours for embryo transfer.
Embryo transfer
Detailed manipulations of embryo transfer were as de-
scribed by Tian et al. [33]. Briefly, the recipient mothers
were injected with 100 IU hCG at the same day the
donor rabbits were injected with 100 IU hCG. About 8
embryos were injected into the unilateral pavilion of ovi-
duct (16 embryos for bilateral pavilion of oviduct) for
each recipient mother.
Mutation detection of targeted genes in embryos and
newborns
Each blastocyst or morula embryo was individually col-
lected in a PCR tube. The DNA of single embryos wasextracted with 6 μL of embryo lysis buffer (0.45% NP40
plus 60 ng/μL protein K in double distilled water at 50°C
for 20 minutes and 90°C for 5 minutes in a BIO-RAD ther-
mal cycler. The DNA of new-born rabbits was extracted
from a small piece of ear tissue using a DNA extraction kit
(Takara) following the manufacturer’s protocol. PCR prod-
ucts spanning the target sites were amplified with Premix
Tag Polymerase (Takara) under the following conditions:
95°C for 3 minutes, 35 cycles of 94°C for 30 seconds, 60°C
for 30 minutes and 72°C for 30 seconds or 1 minutes,
72°C for 5 minutes and 4°C for an indeterminate period.
Sequencing followed.
We performed nested PCR to simultaneously test 5
genes in a single embryo with 25 cycles during first PCR
run and 35 cycles during the second PCR run. All
primers used are listed in Additional file 3: Table S1.
The PCR products showing a different curve compared
with those of WT animals were cloned into the pMD-
18 T vector (Takara). At least 8 TA-clones selected from
each transformation were used for sequencing to obtain
detailed information of the mutation.
Off-target analysis of newborn rabbits
Sites with over 14 bp identical to the sequence of gRNA
(20 bp) and NGG (PAM, 3 bp) in the rabbit genome were
selected as candidate off-target sites. Nine such sites was
selected and screened for the IL2rg gene in 8 IL2rg KO
rabbits and 5 IL2rg/RAG1 KO rabbits, 17 such sites were
screen for TIKI1 in 5 TIKI1 KO rabbits, whilst 3 such sites
were screened for RAG1 in 5 IL2rg/RAG1 KO rabbits.
The primers used to amplify the candidate off-target sites
are listed in Additional file 3: Table S2.
T7E1 assay
PCR products spanning the potential off-target sites were
amplified using the DNA pool of all new-born rabbits as
the template. A mixture of 9 μL of PCR products and 1 μL
of NEB buffer 2 was melted and re-annealed in a thermal
cycler under the following conditions: 95°C for 10 minutes,
95°C to 85°C at 2°C/second, 85°C for 1 minute, 85°C to
25°C at 0.1°C/second, 25°C for 1 minute and 4°C for an in-
definite period. Exactly 6 μL of the re-annealed mixture
was treated with 0.5 uL of T7 endonuclease I (5 units) by
addition of 0.4 μL of NEB buffer 2 and 3.1 μL of dd H2O
at 37°C for 20 minutes. Analysis by 2% agarose-gel electro-
phoresis followed. The gel was stained with 1 μg/mL eth-
idium bromide in Tris-acetate-EDTA buffer for 5 minutes
and then imaged with a gel-imaging system.
Additional files
Additional file 1: Figure S1. Detailed mutations of muti-gene KO in
rabbit embryos (A) Sequenced mutations of the IL2rg, RAG1 and RAG2
genes in in vitro developmental embryos by microinjected of Cas9 mRNA
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http://www.cellregenerationjournal.com/content/3/1/12together with gRNAs for IL2rg, RAG1 and RAG2. (B) Sequenced mutations
of the IL2rg, RAG1, RAG2, TIKI1 and ALB genes occurred in in vitro
developmental embryos by microinjection of Cas9 mRNA together with
gRNAs for IL2rg, RAG1, RAG2, TIKI1 and ALB. For each gene, the WT
sequence is shown at the top with the target sites in underline. Deletions
are indicated by dashes, insertions are indicated in blue and substitutions
are indicated in pink, and the sizes of the deletions (−) or insertions (+)
are shown on the right column.
Additional file 2: Figure S2. Candidate off-target sites are presented in
terms of chromosome location, sequence, overall percent match with the
targets (mismatches are indicated in red) and expected amplicon and
T7EI fragment sizes.
Additional file 3: Table S1. Primer pairs used to amplify the fragments
encompassing the targeted sites of IL2rg, RAG1, RAG2, TIKI1 and ALB.
Table S2. Primer pairs used to amplify the fragments encompassing the
candidate off-targeted sites of IL2rg, RAG1and TIKI1.
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